TABLE 2.
Screening* | Week 8 | Absolute Change | P† | Percent Change | P† | |
---|---|---|---|---|---|---|
Fish oil (n = 47) | ||||||
TG | 665 (402 to 2980) | 362 (133 to 1278) | −283 (−2019 to 682) | <0.001 | −46% (−87 to 114) | <0.001 |
LDL-C | 86 (31 to 152) | 108 (60 to 227) | 30 (−48 to 120) | <0.001 | 37% (−44 to 348) | <0.001 |
HDL-C | 31 (21 to 43) | 32 (22 to 51) | 1 (−9 to 18) | 0.198 | 4% (−24 to 55) | 0.074 |
TC | 246 (147 to 457) | 236 (128 to 450) | −15 (−204 to 105) | 0.028 | −7% (−45 to 42) | 0.043 |
Non-HDL-C | 210 (125 to 436) | 204 (100 to 414) | −13 (−207 to 87) | 0.018 | −7% (−47 to 40) | 0.026 |
Fenofibrate (n = 48) | ||||||
Serum TG | 694.5 (401 to 1922) | 338.5 (103 to 1476) | −367 (−1466 to 319) | <0.001 | −58% (−90 to 67) | <0.001 |
LDL-C | 73 (30 to 160) | 110.5 (63 to 191) | 31.5 (−45 to 101) | <0.001 | 46% (−33 to 233) | <0.001 |
HDL-C | 30 (21 to 42) | 33.5 (7 to 53) | 4 (−17 to 24) | <0.001 | 13% (−71 to 110) | <0.001 |
TC | 243 (158 to 447) | 211.5 (140 to 321) | −21.5 (−289 to 60) | <0.001 | −10% (−65 to 28) | <0.001 |
Non-HDL-C | 210.5 (132 to 421) | 178.5 (112 to 314) | −27 (−300 to 57) | <0.001 | −13% (−71 to 31) | <0.001 |
Note that screening values differ from Table 1 because not all subjects had week 8 evaluations and the numbers of subjects differ from the baseline assessment.
Signed rank test.
TC indicates total cholesterol.